BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27941389)

  • 1. Factors modulating the inflammatory response in acute gouty arthritis.
    Cleophas MC; Crişan TO; Joosten LA
    Curr Opin Rheumatol; 2017 Mar; 29(2):163-170. PubMed ID: 27941389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overnutrition-induced gout: An immune response to NLRP3 inflammasome dysregulation by XOD activity increased in quail.
    Wu H; Wang Y; Ren Z; Li Y; Huang J; Lin Z; Zhang B
    Front Immunol; 2022; 13():1074867. PubMed ID: 36569836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological basis for use of madecassoside in gouty arthritis: anti-inflammatory, anti-hyperuricemic, and NLRP3 inhibition.
    Lu X; Zeng R; Lin J; Hu J; Rong Z; Xu W; Liu Z; Zeng W
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):277-284. PubMed ID: 31084401
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis).
    Busso N; Ea HK
    Reumatismo; 2012 Jan; 63(4):230-7. PubMed ID: 22303529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interleukin-1 and the inflammasome in gout: implications for therapy.
    Pope RM; Tschopp J
    Arthritis Rheum; 2007 Oct; 56(10):3183-8. PubMed ID: 17907163
    [No Abstract]   [Full Text] [Related]  

  • 6. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.
    Amaral FA; Costa VV; Tavares LD; Sachs D; Coelho FM; Fagundes CT; Soriani FM; Silveira TN; Cunha LD; Zamboni DS; Quesniaux V; Peres RS; Cunha TM; Cunha FQ; Ryffel B; Souza DG; Teixeira MM
    Arthritis Rheum; 2012 Feb; 64(2):474-84. PubMed ID: 21952942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doliroside A attenuates monosodium urate crystals-induced inflammation by targeting NLRP3 inflammasome.
    Wei H; Hu C; Xie J; Yang C; Zhao Y; Guo Y; Mei Z; Chen L; Lan Z
    Eur J Pharmacol; 2014 Oct; 740():321-8. PubMed ID: 25064339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome.
    Liu-Bryan R
    Immunol Cell Biol; 2010 Jan; 88(1):20-3. PubMed ID: 19935768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of T cells in the pathogenesis and treatment of gout.
    Wang B; Chen S; Qian H; Zheng Q; Chen R; Liu Y; Shi G
    Int Immunopharmacol; 2020 Nov; 88():106877. PubMed ID: 32805695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators.
    Dhanasekar C; Rasool M
    Eur J Pharmacol; 2016 Sep; 786():116-127. PubMed ID: 27268719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urate-induced immune programming: Consequences for gouty arthritis and hyperuricemia.
    Cabău G; Crișan TO; Klück V; Popp RA; Joosten LAB
    Immunol Rev; 2020 Mar; 294(1):92-105. PubMed ID: 31853991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune and inflammatory mechanisms and therapeutic targets of gout: An update.
    Liu W; Peng J; Wu Y; Ye Z; Zong Z; Wu R; Li H
    Int Immunopharmacol; 2023 Aug; 121():110466. PubMed ID: 37311355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.
    Hu Y; Mao K; Zeng Y; Chen S; Tao Z; Yang C; Sun S; Wu X; Meng G; Sun B
    J Immunol; 2010 Dec; 185(12):7699-705. PubMed ID: 21048113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in crystal-induced acute inflammation.
    Akahoshi T; Murakami Y; Kitasato H
    Curr Opin Rheumatol; 2007 Mar; 19(2):146-50. PubMed ID: 17278929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication.
    Jhang JJ; Lin JH; Yen GC
    J Agric Food Chem; 2018 Jan; 66(4):765-772. PubMed ID: 29293001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of oxidative stress in gouty arthropathy.
    Zamudio-Cuevas Y; Hernández-Díaz C; Pineda C; Reginato AM; Cerna-Cortés JF; Ventura-Ríos L; López-Reyes A
    Clin Rheumatol; 2015 Oct; 34(10):1667-72. PubMed ID: 25854697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-type lectin domain family 12, member A: A common denominator in Behçet's syndrome and acute gouty arthritis.
    Oğuz AK; Yılmaz S; Akar N; Özdağ H; Gürler A; Ateş A; Oygür ÇŞ; Kılıçoğlu SS; Demirtaş S
    Med Hypotheses; 2015 Aug; 85(2):186-91. PubMed ID: 25957656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uric acid crystals and chemotactic cytokines--pathogenesis of an acute gout attack].
    Peichl P
    Wien Med Wochenschr; 1997; 147(16):373-4. PubMed ID: 9446414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.
    Lee HE; Yang G; Kim ND; Jeong S; Jung Y; Choi JY; Park HH; Lee JY
    Sci Rep; 2016 Dec; 6():38622. PubMed ID: 27934918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvacrol Alleviates Hyperuricemia-Induced Oxidative Stress and Inflammation by Modulating the NLRP3/NF-κB Pathwayt.
    Riaz M; Al Kury LT; Atzaz N; Alattar A; Alshaman R; Shah FA; Li S
    Drug Des Devel Ther; 2022; 16():1159-1170. PubMed ID: 35496367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.